Skip to content
HW211208 TCR-based Therapies for Solid Tumors Summit logo

June 27-29, 2022

Boston, MA

EVENT GUIDE
  • Home
  • About
    • About Event
    • Venue
    • FAQs
    • Content Library
  • What’s On?
    • Full Event Guide
    • Speakers
    • Pre-Conference Workshops
    • Agenda
      • Conference Day 1
      • Conference Day 2
  • Partner
    • Why Partner?
    • Partners
  • Take Part
    • Register
    • Contact Us
About › Content Library
  • Home
  • About
    • About Event
    • Venue
    • FAQs
    • Content Library
  • What’s On?
    • Full Event Guide
    • Speakers
    • Pre-Conference Workshops
    • Agenda
      • Conference Day 1
      • Conference Day 2
  • Partner
    • Why Partner?
    • Partners
  • Take Part
    • Register
    • Contact Us
HW211208 TCR-based Therapies for Solid Tumors Summit logo

June 27-29, 2022
Boston, MA

Register & Pay before Friday, May 13 & Save Up to $500

Content Library

Manufacturing Challenges & Considerations for Allogeneic Cell Therapy

by

Hanson Wade Intelligence

Click Here to Download
Beacon

TCR-based Therapy Landscape Review

by

Beacon Adoptive Cell

Click Here to Download
Download the Event Guide! Access the full agenda, speaker faculty, workshop details and audience breakdown

OUR CONTACT DETAILS

T:  (+1) 617 455 4188
E: info@hansonwade.com

VENUE DETAILS

The Colonnade Boston,
120 Huntington Ave,
Boston, MA,
02116

ABOUT US

Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.

LOCATION

SEARCH

ORGANISED BY

HansonWade Logo

Terms & Conditions

Privacy Policy

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok